You are here: Industry Insights > influenza vaccine

News List

Medicago Announces Phase 3 Study of VLP Quadrivalent Influenza Vaccine americanpharmaceuticacreview
September 27, 2017
Medicago announced the start of a Phase 3 efficacy study for its seasonal quadrivalent influenza vaccine (QIV) candidate.
Hong Kong, S.A.R., China doctor found giving expired flu vaccines to patients fiercepharma
August 23, 2017
A doctor in Hong Kong, S.A.R., China Special Administrative Region of China was found giving expired flu vaccines to patients.
AstraZeneca's struggling FluMist loses out on crucial CDC vaccine backing—again fiercepharma
June 29, 2017
Last June, a key CDC vaccines committee stiff-armed AstraZeneca's nasal influenza vaccine based on worries about its effectiveness. Despite the company's efforts to fix things since then, the committee once again advised doctors to eschew FluMist for the
U.S. government tasks Protein Sciences with developing avian influenza vaccines fiercepharma
March 22, 2017
By request of the HHS’ Biomedical Advanced Research and Development Authority, Protein Sciences will start working on two H7N9 vaccine candidates based on new virus strains identified in the fifth epidemic of the disease.
GSK Seeks Expanded Indication for Fluarix® Quadrivalent for Infants Six Months and Older americanpharmaceuticalreview
March 17, 2017
GSK has announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for FLUARIX® QUADRIVALENT (Influenza Vaccine).

Previous page 1 2 Next page